FDA Approved: TEZSPIRE — Supplemental Application (Amgen Inc)

View source ↗

Summary

The FDA approved a supplemental application for TEZSPIRE (tezepelumab-ekko) from Amgen, indicating an update related to its labeling or indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Tezspire (tezepelumab)

Snippet

SUPPL AP for TEZSPIRE (TEZEPELUMAB-EKKO)